The molecular mechanisms of human neurodegenerative diseases have so far been studied in animals models but the validity of extrapolating these studies to human in uncertain. There is a need, therefore, to study human neurons at the cellular and molecular levels of understanding their normal behavior and functioning and the changes which lead to neurodegenerative diseases. The neurodegenerative effects of BetaA or its peptide fragments in vitro have mostly been studied on rat neuronal cells or tissue slices and only in few instances on human cells cultured from cryopreserved brains. Propagation and establishment of long-term cultures of human neurons promises to be a powerful approach in achieving this goal. We propose to propagate and establish long-term cultures of human neuronal cells by utilizing the proliferative property of basic fibroblast growth factor (bFGF). Cell will be characterized according to morphology and phenotypes. Establishment of such cultures will enable us to generate large number of cells from specific areas of the brain using small amounts of scarce fetal tissues. We have already succeeded in propagating and establishing long-term neuronal cultures from rat brain tissues. We will transduce amyloid precursor protein (APP) and Beta-amyloid (BetaA) genes into human and rat neurons and study both the expression of these proteins at the molecular levels and their modulation by factors such as the state of differentiation and growth factors. In In vitro experiments BetaA peptides will be added to neuronal cultures to determine their neurodegenerative effects. The neurotoxic effects of glutamate, a neurotransmitter, on cultured neurons (control) or neuron expressing APP proteins (test) in the absence and in the presence of bFGF will be studied. Parallel cultures of human and rat neuronal cultures will be used for these studies and the results will be compared. This will allow us to determine whether rat neurons can be used as model for studies of human neurodegenerative diseases at the molecular level. The establishment of perpetual human neuronal cultures will enable the studies of their functioning at the cellular and molecular level in general and, specific to this proposal, an understanding of the modulation of BetaA by environmental effectors including neurotransmitter and growth factors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-12
Application #
3726250
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Graves, Lisa V; Holden, Heather M; Van Etten, Emily J et al. (2018) New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. J Int Neuropsychol Soc 24:833-841
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Fong, Lauren K; Yang, Max M; Dos Santos Chaves, Rodrigo et al. (2018) Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-? clearance in human astrocytes. J Biol Chem 293:11341-11357
Edmonds, Emily C; Ard, M Colin; Edland, Steven D et al. (2018) Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study. Alzheimers Dement (N Y) 4:11-18
Spencer, Brian; Brüschweiler, Sven; Sealey-Cardona, Marco et al. (2018) Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. Acta Neuropathol 136:69-87
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17

Showing the most recent 10 out of 914 publications